NCT06283264Not yet recruiting
Assessment of Coeliac Disease in Patients With Type 2 Diabetes
Source: ClinicalTrials.gov · Last updated 28 Feb 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This study aims to screen and diagnose coeliac disease in patients with type 2 diabetes and monitor the effect of gluten-free diet on the metabolic status
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 100 (estimated)
- First submitted
- 14 Dec 2023
- Start date
- 15 Mar 2024
- Primary completion date
- 1 Dec 2026
- Lead sponsor
- Assiut University
- Diseases
- Type 2 diabetes
- NCT number
- NCT06283264
What you commit to
- Study type: Observational
- Planned participants: 100
- From 15 Mar 2024 to the primary completion date, 1 Dec 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients already diagnosed with co-morbid autoimmune disorder
- already diagnosed with coeliac disease
Other
- patient diagnosed as systemic lupus
- diagnosed as rheumatoid arthritis
Who the study is looking for
- adult patients ≥18 years old
- diagnosed with type 2 diabetes mellitus
Age in the registry: 18 years to 75 years · Sex: All
This page is information, not medical advice. Discuss any trial with your doctor.